dpp-4 inhibitor and glp-1 receptor agonist combination not recommended ada Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology DPP-4 inhibitors and GLP-1RAs: cardiovascular
Description
doi: 10.1002/dmrr.2810 34 PratleyREArodaVRLingvayILdemannJAndreassenCNavarriaAet al
hGLP-1, GLP-1, receptor agonist based on human GLP-1
Lincoff, MD, Professor of Neurology
Mol Metab 2014;3:507-17.ArticlePubMedPMC 23
Greater doses provided greater weight loss and caused more side effects such as upset stomach and, in rare instances, dysesthesia (2.3%4.5% of those enrolled)
Scientists are now attempting to add a compound called a myostatin inhibitor to reta, creating a kind of super-duo medication, says Dr
